JPM vs UNH: Which Is the Better Buy?
Side-by-side comparison of JPMorgan Chase & Co. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
JPMorgan Chase & Co. · Financial Services
$316.99
+45.0% upside to fair value
Grade C
High Quality
VS
UnitedHealth Group Incorporated · Healthcare
$353.52
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
JPM trades at a lower forward P/E
(15.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JPM |
UNH |
| Current Price |
$316.99 |
$353.52 |
| Fair Value Estimate |
$459.64 |
$512.60 |
| Upside to Fair Value |
+45.0%
|
+45.0%
|
| Market Cap |
$854.9B |
$320.9B |
| Forward P/E |
15.0x
|
26.7x
|
| EV / EBITDA |
21.8x
|
16.1x
|
| Price / Sales |
3.0x
|
0.7x
|
| Price / FCF |
8.5x
|
16.3x
|
| Revenue Growth YoY |
+6.9%
|
+2.0%
|
| Gross Margin |
60.9%
|
18.8%
|
| Operating Margin |
26.2%
|
4.2%
|
| Return on Equity |
16.3%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
11.79%
|
6.13%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
JPMorgan Chase & Co. is a leading diversified financial services firm with a strong competitive moat driven by its scale, diversified revenue streams, and long-tenured leadership. The company operates across four main segments: Commercial & Investment Bank, Consumer & Community Banking, Asset & Wealth Management, and Corporate, generating $279.75 billion in revenue in fiscal 2025. Its durable com…
UnitedHealth Group Incorporated operates as a leading healthcare company with two main platforms: UnitedHealthcare, providing health benefits coverage, and Optum, offering information and technology services. The company benefits from a durable competitive moat due to its scale, integrated platforms, and broad market reach serving over 170 million consumers. Despite strong revenue growth of 12% y…
Accumulation Zones
| Metric |
JPM |
UNH |
| Zone Low |
$344.73 |
$384.45 |
| Zone High |
$390.69 |
$435.71 |
| In Buy Zone? |
Yes
|
Yes
|